Could a bike ride help your brain? new study explores exercise, cell health, and depression
NCT ID NCT07664540
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how exercise affects a natural cell cleanup process called autophagy, which may be linked to depression. Researchers will have 120 healthy adults do a cycling test and take blood samples to measure changes in autophagy and related genes. The goal is to better understand how lifestyle factors like exercise might influence mental health, which could lead to new prevention or treatment ideas for depression.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how exercise-induced autophagy relates to mood, pointing toward lifestyle-based strategies for depression prevention or treatment.
- What could go wrong
- This is an early exploratory study in healthy people, not patients. It only measures biological markers, not actual depression outcomes, so real-world benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age: 18-40 years * BMI: between 18.5 and 24.9 kg/m2 (SG1/2) or BMI between 25.0 and 39.9 kg/m2 (SG3/4) * ability to understand the study procedure and give consent * Written informed consent * SG1 women: any fitness level * SG2 men: VO2max \< 45 ml/kg/KG29,30 * Available to conduct CPET on menstrual cycle days 1-5 (SG1/3) * No infection with HIV or Hepatitis B/C Exclusion Criteria: * No infectious illness for at least two weeks prior to the test * No vitamin supplementation during the week prior to the performance test * SG3 and SG4: More than 1 hour moderate exercise per week * No use of hormonal contraceptives in the last 6 months before the onset of the study (SG1/3) * a clinically diagnosed menstrual disorder (e.g., polycystic ovarian syndrome or amenorrhea) (SG1/3) * having given birth within the 12 months before inclusion in the study (SG1/3) * pregnancy or breastfeeding (SG1/3) * premenstrual dysphoric disorder (PMDD) (SG1/3) * history of epileptic seizure * history of depression * history of manic or psychotic episode * existing/current eating disorders (bulimia nervosa, anorexia nervosa) within the past 5 years * inability to communicate adequately in speech * inability to follow instructions * regular use of medication other than thyroxine * alcohol consumption as equivalent doses of more than 12 g of pure alcohol per day on average for women and 24 g of pure alcohol per day for men * vegan diet * daily nicotine consumption * currently or history of (regular) consumption of illegal drugs within the last year * known diseases of the cardiovascular system * arterial hypertension above 160/90 mmHg at rest * known pulmonary diseases * arthritis and rheumatic diseases and conditions * hematologic diseases * bronchial asthma * surgery less than 4-6 months ago * orthopedic or other diseases (e.g. neurological) that preclude maximum load on the bicycle ergometer * anemia (\<12.0 g/dl for women and \<14.0 g/dl for men)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression - major depressive disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can brain stimulation rewire how depressed patients learn from rewards?
- Can lay workers in uganda talk depression down?
- Can a computer model outsmart depression in older adults?
- Can a single shot of ketamine calm suicidal distress in the ER?
- Can talk therapy mend more than mood in marital crisis?
- A brain stimulation trial aims to rewire the circuit behind depression